PUBLISHER: The Business Research Company | PRODUCT CODE: 1945404
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945404
Devices for monitoring intracranial pressure (ICP) are medical tools utilized to measure and track the pressure within the skull and brain, particularly in patients facing conditions that may lead to elevated intracranial pressure.
The primary techniques employed in intracranial pressure (ICP) monitoring devices include both invasive and non-invasive approaches. Invasive techniques involve the use of monitoring devices or methods that necessitate the insertion of a probe or sensor directly into the intracranial space or a specific location within the brain. These techniques find application in various medical scenarios such as traumatic brain injury, intracerebral hemorrhage, meningitis, subarachnoid hemorrhage, cerebrospinal fluid (CSF) management, migraine, stroke, hydrocephalus, electroencephalogram (EEG), and others. These devices are utilized by hospitals, ambulatory care facilities, clinics, and various other end-users.
Tariffs are impacting the intracranial pressure monitoring devices market by increasing costs of imported sensors, transducers, electronic components, imaging systems, and precision monitoring equipment. Hospitals and neurology centers in North America and Europe are most affected due to reliance on imported technologies, while Asia-Pacific faces higher equipment costs for advanced diagnostics. These tariffs are increasing capital investment requirements and delaying equipment upgrades. However, they are also encouraging domestic production, regional sourcing of components, and innovation in cost-effective ICP monitoring solutions.
The intracranial pressure (icp) monitoring devices market research report is one of a series of new reports from The Business Research Company that provides intracranial pressure (icp) monitoring devices market statistics, including intracranial pressure (icp) monitoring devices industry global market size, regional shares, competitors with a intracranial pressure (icp) monitoring devices market share, detailed intracranial pressure (icp) monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial pressure (icp) monitoring devices industry. This intracranial pressure (icp) monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intracranial pressure (icp) monitoring devices market size has grown strongly in recent years. It will grow from $1.72 billion in 2025 to $1.84 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increasing incidence of traumatic brain injuries, expansion of neurocritical care units, growth in neurosurgical procedures, rising awareness of intracranial pressure management, availability of advanced imaging technologies.
The intracranial pressure (icp) monitoring devices market size is expected to see strong growth in the next few years. It will grow to $2.47 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing demand for real-time brain monitoring, rising adoption of smart neurological devices, expansion of minimally invasive diagnostic tools, growing investments in neurocritical care infrastructure, technological advancements in sensor accuracy. Major trends in the forecast period include increasing adoption of non-invasive monitoring techniques, rising use of continuous icp monitoring systems, growing integration of digital data analytics, expansion of portable monitoring devices, enhanced focus on early diagnosis and intervention.
The increasing incidence of traumatic brain injury (TBI) cases is anticipated to drive the growth of the intracranial pressure (ICP) monitoring devices market in the future. Traumatic brain injury refers to damage to the brain resulting from an external force or trauma. The rise in TBI cases is primarily attributed to a higher number of motor vehicle accidents, sports injuries, and physical assaults. ICP monitoring devices are essential in managing TBI cases as they provide real-time data regarding the pressure within the skull. For example, in April 2024, the American Association of Neurological Surgeons, a US-based scientific and educational organization, reported from the CDC that approximately 1.7 to 3.8 million traumatic brain injuries occur each year in the United States, with 10 percent stemming from sports and recreational activities. Consequently, the increasing prevalence of traumatic brain injury cases is fueling the demand for intracranial pressure monitoring devices.
Major companies in the intracranial pressure (ICP) monitoring market are focusing on developing advanced solutions such as non-invasive telemetric pressure monitoring systems to provide continuous, accurate, and long-term intracranial pressure assessment. A non-invasive telemetric pressure monitoring system is a device that measures internal body pressures and wirelessly transmits the data for ongoing monitoring without repeated invasive procedures. For instance, in August 2024, Aesculap Inc., a US-based manufacturer, partnered with Christoph Miethke GmbH & Co. KG, a Germany-based medical technology company, and received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for the M.scio(R) System. The system features a fully implantable, non-invasive sensor that delivers continuous, real-time intracranial pressure monitoring at a high sampling rate of 44 Hz, producing detailed pressure curves and clinically relevant morphologies. It requires no calibration, provides stable long-term measurements with less than 2 mmHg drift over four years, and supports optimized patient management through non-invasive telemetric readings.
In December 2024, Integra LifeSciences Holdings Corporation, a US-based medical technology company, acquired the NeuroSensor(TM) Monitor technology and related assets from Novus Monitoring Limited for an undisclosed amount. With this acquisition, Integra aims to strengthen its neurosurgical and intracranial pressure (ICP) monitoring capabilities by incorporating an advanced neuro-monitoring platform into its existing portfolio. Novus Monitoring Limited is a UK-based company specializing in neuro-monitoring solutions.
Major companies operating in the intracranial pressure (icp) monitoring devices market are Medtronic plc, Integra LifeSciences Holding Corporation, Natus Medical Inc., Haiying Medical, Raumedic AG, Sophysa Ltd., Ad-Tech Medical Instrument Corp., Third Eye Diagnostics, Codman & Shurtleff Inc., NeuroWave Systems Inc., Branchpoint Technologies Inc., Cerebrotech Medical Systems Inc., Gaeltec Devices Ltd., Infrascan Inc., NeuroDx Development, NeuroVent Research Inc., Noninvasix, Vivonics Inc., Neural Analytics, Spiegelberg GmbH and Co. KG, HeadSense Medical Ltd., Moberg ICU Solutions, Nisonic AS, Vittamed Corporation, Cerebral Assessment Systems Inc., Orsan Medical Technologies Ltd.
North America was the largest region in the intracranial pressure (ICP) monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intracranial pressure (icp) monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intracranial pressure (icp) monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The intracranial pressure (ICP) monitoring devices market consists of sales of intraparenchymal monitors, subdural monitors, epidural monitors, and ventricular catheters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intracranial Pressure (ICP) Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intracranial pressure (icp) monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intracranial pressure (icp) monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intracranial pressure (icp) monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.